Cargando…
MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
Prostatic cancer (PCa) is a prevalent form of malignancy based on its high associated levels of mortality and morbidity across the world. MicroRNAs (miRNAs) are significant in the advancement of prostatic cancer. The current study is aimed at exploring the potential roles of miR-373 in PCa. In turn,...
Autores principales: | Pang, Jianyi, Dai, Limei, Zhang, Chen, Zhang, Qinglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260310/ https://www.ncbi.nlm.nih.gov/pubmed/34257854 http://dx.doi.org/10.1155/2021/6974225 |
Ejemplares similares
-
Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
por: Healthcare Engineering, Journal of
Publicado: (2023) -
MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer
por: Chen, De, et al.
Publicado: (2015) -
Diverse functions of miR-373 in cancer
por: Wei, Furong, et al.
Publicado: (2015) -
miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition
por: Wang, Lin, et al.
Publicado: (2015) -
Liquiritigenin Inhibits Colorectal Cancer Proliferation, Invasion, and Epithelial-to-Mesenchymal Transition by Decreasing Expression of Runt-Related Transcription Factor 2
por: Meng, Fan-Chun, et al.
Publicado: (2019)